chrisvoncsefalvay/vaers-outcomes huggingface dataset:
prolonged arm pain at injection site. unable to raise arms without pain. difficulty lifting lightweight items. felt like intense muscle bruise. no visible bruise. pain in left arm lasts 11 months. pain in right arm lasted 7 months.
2nd dose inadvertently given early Narrative:  Patient was inadvertently given 2nd Pfizer dose on day 14 instead of day 21.
get sick with flu twice; Initial information received on 18-Oct-2023 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves male patient (unknown age) who get sick with flu twice after receiving INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant disease or risk factor and family history were not provided.   On an unknown date, the patient received a dose of suspect Influenza Vaccine by unknown manufacturer (strength, formulation, dose, route, batch number and expiry date: unknown) in unknown administration site for prophylactic vaccination. Information on the batch number was requested  On an unknown date the patient got sick with flu twice  (Influenza) (unknown latency).  Reporter Commented: 53 years of never getting a flu shot and never contracted the flu. No Covid shot was exposed a few times no covid. Watched my dad get flu shot ever year and every year get sick with flu twice. No thx(therapeutic) ill stick to my immune system working.   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Patient received his vaccine and a few minutes later felt like he was going to pass out. He said his head felt  foggy and just didn't fell well. He was brought back to med observation 1 by wheelchair. He looked pale and felt clammy. We laid him down on the stretcher and almost immediately felt better. He had a water when he came to us and he was given some crackers to eat. His color returned to normal and skin felt warmer. He stated that he was ready to leave. His wife was out in the car waiting for him. We took vitals at 10:12 am - heart rate 79, o2 98, BP 115/83, at 10:16 am heart rate 80, o2 99, BP 125/79, at 10:20 am heart rate 80, o2 99, BP 127/76. We released patients with other at 10:21am.
Started having pain in lungs; Having palpitations; Shortness of breath; This is a spontaneous report from a contactable nurse, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205), via an unspecified route of administration and an unspecified anatomical location on 10Mar2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208), via an unspecified route of administration in the left arm on 31Mar2021 at 13:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications were not reported. The patient previously received BACTRIM for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unspecified date in Mar2021, the patient experienced palpitations and shortness of breath. The patient reported that the palpitations and shortness of breath started since she was vaccinated. On 02May2021, the patient experienced pain in lungs. The patient reported that she had no symptoms or issues until after she received the COVID 19 vaccination. On an unspecified date in 2021, the patient underwent tests and blood works which were all found to be normal. The patient reported that she was scheduled for further tests. The events resulted in a doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events palpitations, shortness of breath and pain in lungs was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
5/23/2021-Pt received J&J vaccine at pharmacy today approx one hour prior to arriving to the ER, passed out after receiving the vaccine in the room at the pharmacy.  Pharmacist was in the room with pt and he had no injuries/did not fall. After leaving pharmacy he passed out again in the car and was shaking per pts wife, then started vomiting. He arrived to the ER c/o feeling 'like crap." vitals with normal bp, temp, RR , hr 69. given 1 Liter normal saline. he was observed in the ER and discharged home to recover.
Delayed (5 days after shot) allergic reaction at the injection site- stiff, swollen arm, which was painful, itchy, red, and hard to the touch. This lasted for about 4 days
Fever, chills, nausea, altered sense of taste, migraine, dizziness, nasal congestion, swelling and muscle soreness at administration site  Lasted for about 12 hours, only nausea continued for 24 hours  Ibuprofen and Naproxen Sodium (NSAIDs) were used from home and provided sufficient treatment of symptoms
pt recv vax 15JUL96 & 8AUG96 exp zoster rash on rt side of face including rt eye;severe swelling, conjunctival involvement & cellulitis;pt hosp x 4 days w/high fever; cult was positive for varicella virus & group A beta hemolytic strep
EXTREME HAIRLOSS! It?s been almost two months and I?ve lost about half of my hair.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Weakness-Severe
This case was reported by a medical assistant and described the occurrence of injection site cellulitis in a 15 month old female patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed (Infanrix).  On an unspecified date, the patient received a dose of Infanrix.  At an unspecified date, the patient received a dose of Infanrix.  At an unspecified time following the administration of Infanrix, the patient experienced a fever.  The outcome of the fever was not specified.  On 07/01/2004, the patient received the fourth dose of Infanrix in the left arm.  Approximately one day following the administration of Infanrix, on 07/02/2004, the patient developed an area of deep, redness, and pain the size of a quarter at the injection site, there was no swelling.  On 07/07/2004, the patient was seen by the vaccine provider, who made a diagnosis of injection site cellulitis and prescribed cephalexin.  The medical assistant said that the patient did not come in for a recheck so she felt that the patient was ok.  The medical assistant initially considered the injection site reaction to probably be related to vaccination with Infanrix and a problem with the specific lot number of Infanrix.  Subsequently she stated that the injection site cellulitis was possibly related to vaccination with Infanrix.
Fatigue, nasal congestion and headache immediately after vaccination on 2/26/21 and that night fast heart rate,  burning lymph nodes on right side, burning tissue around right hip prosthesis, burning right eye and tongue, severe pain in right glute muscles and lower spine,  back of neck felt still and slightly swollen, lightheaded and felt cold. Symptoms continued the following day. By 2/28/21 burning symptoms and fast heart rate ceased, still had dull headache, congestion and fatigue, plus pain in lower back and right hip. On 3/02/21 noticed hard lump, like a boil, near right hip prosthetis scar, felt cold, tired and dizzy all day. On 3/03/21 another hard lump, like a boil, on left neck.
Area is still red; Area is still itchy; Lymph node under the arm pit is sore; This case was reported by a consumer via interactive digital media and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 26th April 2022, the patient received the 1st dose of Shingles vaccine. On 26th April 2022, less than a day after receiving Shingles vaccine, the patient experienced injection site erythema, injection site itching and lymph node pain. On an unknown date, the outcome of the injection site erythema, injection site itching and lymph node pain were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, injection site itching and lymph node pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 02-MAY-2022 Reporter's comments: The case was reported via interactive digital media. The patient received first shingles vaccine last Tuesday and the area was red and itchy. The patient also noticed the lymph node under the arm pit was sore. The reporter asked as was this normal 6 days later.
Client reported dizziness and sweating 25 minutes after  vaccination.  Onsite EMS assessed vital signs.  BP 100/60, Water provided.  BP reached after 5 minutes 109/55.  Observed for an additional 20 minutes.  Reported feeling "normal".  Declined further observation.  Client exited site with family members.
Patient was administered fourth full (0.5ml) dose of Moderna MRNA vaccine.  Patient and patient's spouse were both adamant that patient had not received third full dose which she qualified for since she attests to being immunocompromised.  However, MA failed to check patient's chart prior to vaccine administration and took patient at her word.  Upon documentation, MA discovered patient had already received three full doses of Moderna MRNA Covid-19 Vaccine and MA had just administered a fourth full dose.  MA immediately informed lead PCP of what had occurred.  Lead PCP examined patient and addressed all questions and concerns patient had.  Patient's chart had been flagged to avoid patient receiving any additional COVID vaccines.
6 hours of irritability, high pitched cry intermittent on day of vaccine & irritability (more than nl) the day following vaccination pt was consolable in mother's arms. Afebrile.
COVID-19 vaccination-associated Acute myocarditis; This literature-non-study case was reported in a literature article and describes the occurrence of MYOCARDITIS (COVID-19 vaccination-associated Acute myocarditis) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.        No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYOCARDITIS (COVID-19 vaccination-associated Acute myocarditis) (seriousness criterion medically significant). At the time of the report, MYOCARDITIS (COVID-19 vaccination-associated Acute myocarditis) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medication was not reported.  Company Comment: This literature non-study case concerns a male patient of unknown age, with no medical history reported, who experienced the expected and serious (due to medically significant) AESI of Myocarditis, which occurred on an unknown date after an unspecified dose of mRNA-1273 vaccine. No information disclosed about diagnostic tests performed, clinical course or treatments received. The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2022-673581 (Linked Report).; Sender's Comments: This literature non-study case concerns a male patient of unknown age, with no medical history reported, who experienced the expected and serious (due to medically significant) AESI of Myocarditis, which occurred on an unknown date after an unspecified dose of mRNA-1273 vaccine. No information disclosed about diagnostic tests performed, clinical course or treatments received. The benefit-risk relationship of mRNA-1273 is not affected by this report. US-MODERNATX, INC.-MOD-2022-673581:Male, patient 2
warmth in my face; tingling in my face; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (warmth in my face) and PARAESTHESIA (tingling in my face) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced FEELING HOT (warmth in my face) and PARAESTHESIA (tingling in my face). At the time of the report, FEELING HOT (warmth in my face) and PARAESTHESIA (tingling in my face) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient stated that symptoms lasted about 15 minutes and subsided after turning on the air conditioning.  Concomitant product information, if any, was not provided by the reporter. Treatment information, if any, was not provided    Reporter did not allow further contact
Knee surgery was on 17DEC21, COVID booster was completed on 20DEC21. Symptoms started sometime around 20DEC21. Symptoms included calf tightness/soreness and escalated into pain by 0400 on 24DEC21. Patient went into the ER at approx 0430 on 24DEC21 where she was admitted with a positive DDimer test and sent to CT and Ultrasound for blood clots. Pt was diagnosed with Bilateral Pulmonary Embolism later that day and admitted to the hospital overnight. No heart damager was found, pt was released at 1300 on 25DEC21 with a prescription of blood thinners and additional follow-up appointments. It is unclear if PE was from the knee surgery, booster shot or combination of both. Pt is 29 y/o service member in good health.
its been over 1 and half hr. and heartbeat is over 100/a rapid heart beat; This is a spontaneous report from a contactable consumer or other non hcp(patient). A 69 year old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13May2021 (Batch/Lot number was not reported)(At the age of 69 years old) as DOSE 1, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 13May2021 the patient stated that its been over 1 and half hr and heartbeat is over 100 rapid heart beat . Patient stated that she wanted to know what is considered a rapid heartbeat and how long before she should be concerned about it. its been over 1 and half hr. and heartbeat is over 100. She received her first dose of the Pfizer covid vaccine today .The patient underwent lab tests and procedures which included heart rate increased: 100 on 13May2021 .The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
MCV4 given at 11:23AM; pt fainted immediately; RN laid pt on floor, pts legs were elevated immediately; pt B/P at 11:25AM 110/60; alert, responsive, verbal; ft still elevated; 11:40AM pt sat up, ate cracker, drank some water, felt fine; 11:50AM B/P 96/60; pt left HD at 11:51AM for home.
pt recvd vax; 17 days later exp numbness of distal toes & fingers progressing to abdo & difficulty walking; 17oct94 seen in er;24oct adm to hosp; tx iv steroids x 3 days then po steroids;discharged 26oct; recovered;
The Moderna Bivalent  Vaccine had expired on 5-19-2023. Inmate had no sign and symptoms. no adverse outcomes to date.
seizures; This is a spontaneous report received from a contactable reporter (Consumer) from medical information team. The reporter is the parent (mother).  A 31-year-old male patient received BNT162b2 on 26Jan2021 as dose 2, single (Lot number: EJ1686, Expiration Date: Mar2021) at the age of 31 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "Atrial bigeminy" (unspecified if ongoing), notes: Atrial bigeminy diagnosed at three years old. Cardiologists and neurologist said his heart was fine and this was nothing contributing. He was always healthy when covid hit. Patient did not have family history relevant to adverse events. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose 1, single, Lot: EK9321 or EK4321, thinks it is EK9321, Expiration: Apr2021), administration date: 05Jan2021, when the patient was 31-year-old, for COVID-19 immunization. The following information was reported: SEIZURE (medically significant) with onset Mar2021, outcome "not recovered", described as "seizures". He did not remember the month exactly but thought the seizures started in Mar2021. In Jul2021 was when they became monthly and Oct2021 was when the seizures increased to more frequently than monthly. The event "seizures" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of seizure. They put him on one medication for seizures called Lacosamide and then he was still having seizures so they added an additional medication, Lamotrigine.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201283002 Same patient, similar event, different dose (dose 3);
headache; redness, soreness and itchiness on her arm that lasted a week; redness, soreness and itchiness on her arm that lasted a week; redness, soreness and itchiness on her arm that lasted a week; This is a spontaneous report from a contactable nurse (patient).  A female patient of an unspecified age (reported as Age: 51; Unit: Unknown) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number not provided), via an unspecified route of administration on 19Dec2020 at SINGLE DOSE for COVID-19 immunization. Medical history and concomitant medications were not reported.  For the first two days (on 21Dec2020) she had a headache, treated with paracetamol (TYLENOL) and headache went away. Then she developed redness, soreness and itchiness on her arm in Dec2020 that lasted a week.  This week these side effects have been more intermittent. She queried if it was okay to receive second dose on 08Jan2021. The patient recovered from the events in Dec2020.  Information on the batch/lot number has been requested.
Pt received pfizer first dose at 1136. Patient ran straight to bathroom, nurse followed her. Pt vomited. Stated "I don't feel well." Patient collapsed. Patient stated, " I can't breathe, my throat is closing up." Vital signs taken, not within normal limits. O2 sats at 86, epi x1 given at 1140. O2 6 L at 100% given at 1140. 911 called. Paramedics arrived, patient taken to ED at 1158.
Began with itching at the injection site approximately a week after I received the shot-  followed by swelling of the muscle and a red patch that is 2? x 1.5? in size...   Took Advil to relieve the soreness and used a hydrocortisone creme to relieve the itching
Per EMT report, approximately 5 minutes after vaccination,  client had seizure lasting approximately 3 minutes. Client is hearing impaired and has a history of epileptic seizures. Spouse reports last seizure event x3 weeks ago.  Per EMT/Paramedic, airway was maintained.  EMS was called, after seizure event, client was awake, respirations even and unlabored, skin warm and dry, client was incontinent of urine, no acute distress. Spouse answered EMS questions on behalf of client as client is deaf.  Client refused transport to hospital, but was transported to vehicle without further incident.
Strong pains in lower abdomen the following evening, roughly 24 hrs after injection, and considerable blood in urine the following day roughly 8 hrs later. Urine dark pink to red. Bleeding lasted for 3 days after first dose. Bleeding still ongoing currently.
buckling and hyperextending; dislocated finger; all foot bones moving; every joint slipped out of place; can't bend; sacrum and buttock burning; light headed; Body tender; Felt jowly and loose; Migraine; headaches; Searing left knee pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (light headed) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0A16M20 and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included SUMATRIPTAN SUCCINATE (IMITREX DF) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced MIGRAINE (Migraine; headaches) and ARTHRALGIA (Searing left knee pain). On 01-Mar-2021, the patient experienced FEELING ABNORMAL (Felt jowly and loose). On an unknown date, the patient experienced DIZZINESS (light headed) (seriousness criterion medically significant), JOINT HYPEREXTENSION (buckling and hyperextending), JOINT DISLOCATION (dislocated finger; all foot bones moving; every joint slipped out of place), JOINT RANGE OF MOTION DECREASED (can't bend), SKIN IRRITATION (sacrum and buttock burning) and MYALGIA (Body tender). At the time of the report, DIZZINESS (light headed), MIGRAINE (Migraine; headaches), FEELING ABNORMAL (Felt jowly and loose), JOINT HYPEREXTENSION (buckling and hyperextending), JOINT DISLOCATION (dislocated finger; all foot bones moving; every joint slipped out of place), JOINT RANGE OF MOTION DECREASED (can't bend), SKIN IRRITATION (sacrum and buttock burning), ARTHRALGIA (Searing left knee pain) and MYALGIA (Body tender) outcome was unknown.            The patient received treatment with prednisone and sumatriptan.  Very limited information regarding these events has been provided at this time. Further information has been requested.   This case was linked to MOD-2021-058046 (Patient Link).; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
Spike in BG (>323); Chills throughout the day; Fatigue (slept 12 hours); Mild aches; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue (slept 12 hours)), PAIN (Mild aches), BLOOD GLUCOSE INCREASED (Spike in BG (>323)) and CHILLS (Chills throughout the day) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     Concomitant products included INSULIN DEGLUDEC (TRESIBA), QUINAPRIL, OMEPRAZOLE, Novolog Tresiba, METFORMIN, HCTZ and SIMVASTATIN for an unknown indication.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced FATIGUE (Fatigue (slept 12 hours)), PAIN (Mild aches) and CHILLS (Chills throughout the day). On 15-Mar-2021, the patient experienced BLOOD GLUCOSE INCREASED (Spike in BG (>323)). At the time of the report, FATIGUE (Fatigue (slept 12 hours)), PAIN (Mild aches), BLOOD GLUCOSE INCREASED (Spike in BG (>323)) and CHILLS (Chills throughout the day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.